These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10765934)

  • 21. [Mixed connective tissue disease--etiology, pathogenesis, clinical significance, treatment].
    Zdrojewicz Z; Budzyń-Kozioł E; Puławska J
    Postepy Hig Med Dosw; 1999; 53(5):751-66. PubMed ID: 10645148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies to the nucleolar organizer antigen NOR-90 in children with systemic rheumatic diseases.
    Fritzler MJ; von Muhlen CA; Toffoli SM; Staub HL; Laxer RM
    J Rheumatol; 1995 Mar; 22(3):521-4. PubMed ID: 7783073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B cell epitopes of the heterogeneous nuclear ribonucleoprotein A2: identification of a new specific antibody marker for active lupus disease.
    Schett G; Dumortier H; Hoefler E; Muller S; Steiner G
    Ann Rheum Dis; 2009 May; 68(5):729-35. PubMed ID: 18495733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential isotype recognition of two centromere associated polypeptides by immunoblotting in connective tissue disease.
    McHugh NJ; James IE; Maddison PJ
    Clin Exp Immunol; 1988 Jun; 72(3):457-64. PubMed ID: 3048806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies that stabilize U1snRNP are a significant component of human autoantibodies to snRNP and delay proteolysis of sm antigens in vitro.
    Satoh M; Akaogi J; Kuroda Y; Nacionales DC; Yoshida H; Yamasaki Y; Reeves WH
    J Rheumatol; 2004 Dec; 31(12):2382-9. PubMed ID: 15570638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue disease.
    Mesa A; Somarelli JA; Wu W; Martinez L; Blom MB; Greidinger EL; Herrera RJ
    Lupus; 2013 Nov; 22(13):1371-81. PubMed ID: 24158973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The appearance of U1 RNP antibody specificities in sequential autoimmune human antisera follows a characteristic order that implicates the U1-70 kd and B'/B proteins as predominant U1 RNP immunogens.
    Greidinger EL; Hoffman RW
    Arthritis Rheum; 2001 Feb; 44(2):368-75. PubMed ID: 11229468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensorineural hearing loss in patients with mixed connective tissue disease: immunological markers and cytokine levels.
    Hajas A; Szodoray P; Barath S; Sipka S; Rezes S; Zeher M; Sziklai I; Szegedi G; Bodolay E
    J Rheumatol; 2009 Sep; 36(9):1930-6. PubMed ID: 19684145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients.
    Dieudé M; Senécal JL; Raymond Y
    Arthritis Rheum; 2004 Oct; 50(10):3221-31. PubMed ID: 15476243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overlapping syndromes, undifferentiated connective tissue disease, and other fibrosing conditions.
    Kallenberg CG
    Curr Opin Rheumatol; 1992 Dec; 4(6):837-42. PubMed ID: 1457278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis.
    Asano Y; Ihn H; Yamane K; Kubo M; Tamaki K
    J Invest Dermatol; 2003 Feb; 120(2):204-10. PubMed ID: 12542523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of clinical and serologic markers in systemic lupus erythematosus and overlap syndrome: a review of 247 patients.
    Ginsburg WW; Conn DL; Bunch TW; McDuffie FC
    J Rheumatol; 1983 Apr; 10(2):235-41. PubMed ID: 6864677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blotting patterns of IgG anti-(U1)RNP antibodies in mixed connective tissue disease.
    Ghirardello A; Doria A; Vesco P; Vaccaro E; Bernardi C; Catani C; Fagiolo U; Gambari PF
    Rheumatol Int; 1996; 16(4):145-50. PubMed ID: 8961378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
    Appelboom T; Kahn MF; Peltier AP; de SEZE S
    Ann Med Interne (Paris); 1974 Nov; 125(11):841-8. PubMed ID: 4218716
    [No Abstract]   [Full Text] [Related]  

  • 35. Autoimmune response to U1 small nuclear ribonucleoprotein (U1 snRNP) associated with cytomegalovirus infection.
    Newkirk MM; van Venrooij WJ; Marshall GS
    Arthritis Res; 2001; 3(4):253-8. PubMed ID: 11438044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of an inhibitory element within the human 68-kDa (U1) ribonucleoprotein antigen.
    Northemann W; Berg H; Stahnke G; Walter M; Hunt N; Fenning S
    Protein Expr Purif; 1995 Dec; 6(6):748-56. PubMed ID: 8746626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse.
    Amigues JM; Cantagrel A; Abbal M; Mazieres B
    J Rheumatol; 1996 Dec; 23(12):2055-62. PubMed ID: 8970041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease.
    Somarelli JA; Mesa A; Rodriguez R; Avellan R; Martinez L; Zang YJ; Greidinger EL; Herrera RJ
    Lupus; 2011 Mar; 20(3):274-89. PubMed ID: 21362751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships between autoantibody responses to deletion mutants of Ki antigen and clinical manifestations of lupus.
    Matsudaira R; Takeuchi K; Takasaki Y; Yano T; Matsushita M; Hashimoto H
    J Rheumatol; 2003 Jun; 30(6):1208-14. PubMed ID: 12784391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
    Frostegård J; Svenungsson E; Wu R; Gunnarsson I; Lundberg IE; Klareskog L; Hörkkö S; Witztum JL
    Arthritis Rheum; 2005 Jan; 52(1):192-200. PubMed ID: 15641060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.